From: Dosimetry study of three-dimensional print template for 125I implantation therapy
First author and year | Representativenessa | Selection of non-exposed b | Ascertainment of exposurec | Incident diseased | Comparabilitye | Assessment of outcomef | Length of follow-upg | Adequacy of follow-uph |
---|---|---|---|---|---|---|---|---|
Hongtao [12] 2016 | A | A | A | A | C | B | A | A |
Han [13] 2017 | A | A | A | A | B | B | A | A |
Huang [14] 2018 | A | A | A | A | B | B | A | A |
Cao [15] 2017 | A | A | A | A | C | B | A | A |
Pan [16] 2018 | A | A | A | A | B | B | A | A |
Shen [17] 2018 | A | A | A | A | A | B | A | A |
Zheng [18] 2019 | A | A | A | A | C | B | A | A |
Di [19] 2017 | A | A | A | A | C | B | A | A |
Ji [20] 2017 | A | N.A | A | A | N.A | B | A | A |
Wang [21] 2016 | A | N.A | A | A | N.A | B | A | A |
Yuliang[22] 2016 | A | N.A | A | A | N.A | B | A | A |
Jiang [23] 2017 | A | N.A | A | A | N.A | B | A | A |
Zhe [24] 2017 | A | N.A | A | A | N.A | B | A | A |
Ji [25] 2019 | A | A | A | A | A | B | A | A |
Ang [26] 2019 | A | A | A | A | A | B | A | A |
Xuemin [27] 2018 | A | A | A | A | A | B | A | A |